Malaria & Tropical Disease Research — Human Serum AB for Plasmodium falciparum Culture
Plasmodium falciparum in vitro culture is the cornerstone of malaria drug discovery, vaccine development, and parasite biology research. The Trager and Jensen protocol (1976) established human red blood cells and human serum as the required culture components — and this remains the standard today. SeamlessBio supplies Human Serum Type AB Off-the-Clot for Plasmodium culture and Human Serum AB Heat Inactivated for PBMC-based immunological assays in malaria and tropical disease research.
Standard Protocol — Plasmodium falciparum Continuous Culture
| Parameter | Specification |
|---|---|
| Base medium | RPMI-1640 + 25 mM HEPES + 0.2% NaHCO₃ |
| Serum supplement | 5% Human Serum Type AB OTC (Trager & Jensen standard protocol) |
| RBC source | Type O+ human erythrocytes — 2–5% haematocrit |
| Atmosphere | 5% CO₂ / 5% O₂ / 90% N₂ (candle jar or gas mixture) |
| Temperature | 37°C |
| Serum alternative | Albumax I or II (lipid-rich BSA) — serum-free option for defined conditions |
Applications — Full Portfolio for Malaria & Tropical Disease Research
| Application | Recommended Product | Protocol Note |
|---|---|---|
| P. falciparum continuous culture | Human Serum AB OTC (native) — 5% | Trager & Jensen protocol. Native serum — complement intact for natural growth conditions. Type AB — no RBC lysis from anti-A/B antibodies. |
| Drug susceptibility assay (RSA, DISA) | Human Serum AB OTC — 5% | Human serum protein binding of antimalarial compounds (chloroquine, artemisinin, lumefantrine) is physiologically relevant — AlbuMAX underestimates protein binding and overestimates free drug concentration. |
| PBMC stimulation — malaria antigens | Human Serum AB Heat Inactivated — 5–10% | Standard PBMC stimulation protocol in malaria immunology: RPMI-1640 + 5% Human Serum AB HI. HI eliminates complement-mediated PBMC lysis during antigen stimulation. |
| IFN-γ ELISpot — malaria vaccine immunogenicity | Human Serum AB HI or FBS Very Low Endotoxin ≤1 EU/mL | Vaccine immunogenicity ELISpot for malaria antigens (RTS,S, R21, blood-stage antigens) — Human Serum AB HI provides species-matched matrix for optimal T cell responses. |
| Opsonophagocytosis assay (OPKA) | Human Serum AB OTC (native) — 10–25% as complement source | Opsonic phagocytosis killing assay — requires active human complement. Human IgG + human complement together for physiological opsonisation of P. falciparum-infected RBCs. |
| Leishmania / Trypanosoma culture | FBS Low Endotoxin ≤5 EU/mL — 10–20% | Leishmania promastigotes (SDM-79, M199 medium) and Trypanosoma (HMI-9 medium) require FBS as growth supplement. Low Endotoxin grade reduces non-specific innate immune activation in macrophage infection models. |
| Toxoplasma gondii infection assays | FBS Low Endotoxin ≤5 EU/mL — 10% | HFF or Vero host cells for T. gondii propagation. Low Endotoxin FBS reduces background cytokine production in macrophage infection models. |
| Human complement studies | Guinea Pig Serum as complement source in classical complement fixation assays | Guinea pig complement is standard for complement fixation tests (CFT) used in tropical disease serology — Brucella, Leishmania, Trypanosoma CFT diagnostics. |
Why Human Serum AB OTC vs AlbuMAX for Plasmodium Culture
| Parameter | Human Serum AB OTC | AlbuMAX I/II |
|---|---|---|
| Physiological relevance | ✅ Native human serum — closest to in vivo conditions | Lipid-enriched BSA — defined but non-physiological |
| Drug susceptibility testing | ✅ Correct protein binding of antimalarials | Overestimates free drug — underestimates protein binding |
| Lot-to-lot variability | Pooled donors — SeamlessBio batch reservation minimises impact | Lower variability — defined composition |
| Complement activity | Active — relevant for some invasion assays | No complement |
| Cost | Higher | Lower for routine culture |
| Published standard | ✅ Trager & Jensen 1976 — WHO malaria reference protocol | Alternative — widely used for routine passaging |
Frequently Asked Questions
Why must serum be Type AB for Plasmodium culture?
Plasmodium falciparum replicates inside human red blood cells. Anti-A and anti-B antibodies present in Type A, B, or O serum cause agglutination and haemolysis of the erythrocytes used as host cells — destroying the substrate for parasite replication. Type AB serum contains neither anti-A nor anti-B antibodies and is therefore compatible with RBC preparations from any blood group donor. This is the universal standard for P. falciparum continuous culture.
Should native (OTC) or heat inactivated serum be used for Plasmodium culture?
Native off-the-clot serum is standard for continuous P. falciparum culture and drug susceptibility assays — complement activity in native serum does not prevent parasite growth under standard culture conditions. Heat inactivated serum is used for PBMC-based immunological assays (ELISpot, proliferation, cytokine assays) where complement-mediated lysis of activated immune cells must be prevented.
Is Human Serum AB available from EU donors?
Yes — SeamlessBio supplies Human Serum Type AB OTC from EU-certified blood donor centres with full viral testing documentation (HIV, HBV, HCV, CMV, EBV, Parvovirus B19). EU origin is preferred for laboratories with European regulatory requirements. US origin is also available. All lots include CoA, CoO, and viral testing panel.
Related Applications
| Application | Link |
|---|---|
| PBMC & Immunology | PBMC & Immunology Guide → |
| Cytotoxicity Assays | Cytotoxicity Assay Guide → |
| Human Serum AB OTC product page | Human Serum AB OTC → |
Technical enquiries: info@seamlessbio.de | +49 851 37932226